Caris & Co Initiates Coverage on Cinemark (CNK)
More News related to CNK
- Glenn Beck's Heartwarming Holiday Event The Christmas Sweater Comes to Life on the Big Screen LIVE in December
- Cinemark Holdings (CNK) Reports Q3 EPS of $0.19, Beats by 2c; Declares $0.18 Qtr. Dividend
- Cinemark Holdings, Inc. Reports Results for Third Quarter 2008 and Declares Quarterly Cash Dividend
- National CineMedia, Inc. Reports Results for Third Quarter Fiscal 2008
- National CineMedia, Inc. Announces Third Quarter 2008 Earnings Release Date and Conference Call
More News related to New Coverage
- Citi Initiates Coverage on US Soft Drink Makers
- William Blair Initiates Coverage on Data Networking Stocks
- Caris Starts Coverage on Ariba (ARBA), Concur (CNQR), salesforce.com (CRM), Taleo (TLEO)
- Oppenheimer Initiates Coverage on ViroPharma (VPHM)
- Oppenheimer Initiates Coverage on Cadence Pharmaceuticals (CADX) with an Outperform
Caris & Co initiates coverage on Cinemark (NYSE: CNK) with an Above Average rating. Price target $17.
Cinemark Holdings, Inc. is a player in the motion picture exhibition industry, with 408 theatres and 4,665 screens in the United States and Latin America.
Related Categories
New CoverageStocks Mentioned
+0.17Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
